The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence

Natasha Masub1,2, Julie K Nguyen1,2, Evan Austin1,2

  • 1Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, New York.

Abstract

Insights

Antivascular agents show promise for treating melasma, a hyperpigmentation disorder. Tranexamic acid and laser therapies targeting vascular abnormalities are effective, but more research is needed.

Area of Science:

  • Dermatology
  • Hyperpigmentation Disorders
  • Vascular Biology

Background:

  • Melasma is a common acquired hyperpigmentation disorder.
  • Symmetric brown patches on the face are characteristic of melasma.
  • Vascular abnormalities are implicated in melasma pathogenesis.

Purpose of the Study:

  • Evaluate evidence on antivascular agents for melasma treatment.
  • Assess the safety and efficacy of these therapies.
  • Provide clinical recommendations based on current research.

Main Methods:

  • Systematic review of PubMed, EMBASE, and Cochrane databases.
  • Included original research on vascularity and antivascular therapeutics in melasma.
  • Followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Main Results:

  • Identified 34 original research articles.
  • Included 4 laboratory, 15 diagnostic, and 15 therapeutic studies.
  • Found promising evidence for tranexamic acid and laser/light therapies.

Conclusions:

  • Tranexamic acid and laser therapies show potential for treating melasma's vascular component.
  • More rigorous clinical trials are needed to confirm efficacy.
  • Antivascular agents may be considered for melasma treatment; further research is warranted.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.1K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.4K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
142